Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Sept 2026 for Phio Pharmaceuticals Corp., €4,522.
Filing timeline
BuySaleRonald Todd Plott
Insider track record
Disclosed buys
3
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
3
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -12.7%Entry US$1.18 · Close 29 Sept 2026 US$1.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ronald Todd Plott: trading record in brief
All filings by Ronald Todd Plott on record concern Phio Pharmaceuticals Corp. In total, 4 filings cover trades dated from 19 August 2026 to 29 September 2026.
The open-market record is one-sided, with 3 purchases worth €24k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant.
In size, the median ticket on the buying side is €4,573. Scaled by market value, the purchases weigh a median 0.043% of market cap (sample: 3 purchases). Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 30 September 2026 came the latest disclosure, an open-market purchase for €4,522 in Phio Pharmaceuticals Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ronald Todd Plott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
5,000 shares@ US$1.03Common Stock, $.0001 par valueSEC:0001683168-26-007499:0
Canonical exit: 27 Dec 2026 (T+90)
5,000 shares@ US$1.04Common Stock, $.0001 par valueSEC:0001683168-26-007499:1
Canonical exit: 28 Dec 2026 (T+90)
17,000 shares0Common Stock, $.0001 par valueSEC:0001683168-26-007482:0
15,000 shares@ US$1.140.14% mcap100.0% of flowCommon Stock, $.0001 par valueSEC:0001683168-26-006620:0
Canonical exit: 17 Nov 2026 (T+90)
4 of 4 declarations
